MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT

Yang Wang1,2, Ning Shao1,2, Xueying Mao3

  • 1Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China.

Oncotarget
|June 23, 2016
PubMed

Insights

MicroRNA miR-4638-5p is underexpressed in castration-resistant prostate cancer (CRPC). Its loss promotes CRPC growth via Kidins220 and the PI3K/AKT pathway, offering potential therapeutic targets.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are crucial regulators in prostate cancer progression.
  • Castration-resistant prostate cancer (CRPC) remains a significant clinical challenge.
  • Identifying molecular drivers of CRPC is essential for developing new therapies.

Purpose of the Study:

  • To identify microRNAs associated with the development of castration resistance in prostate cancer.
  • To elucidate the functional role of miR-4638-5p in prostate cancer progression.
  • To investigate the downstream targets and pathways regulated by miR-4638-5p.

Main Methods:

  • MicroRNA microarray analysis comparing CRPC and androgen-dependent prostate cancer (ADPC) samples.
  • Quantitative PCR (qPCR) for miRNA expression validation.
  • In vitro and in vivo functional assays to assess miR-4638-5p's role.
  • Target gene identification and pathway analysis (e.g., Kidins220, PI3K/AKT, VEGF).

Main Results:

  • miR-4638-5p was commonly underexpressed in CRPC compared to ADPC.
  • Restoration of miR-4638-5p inhibited androgen-independent growth of prostate cancer cells.
  • Kidins220 was identified as a direct target of miR-4638-5p, and its knockdown mimicked miR-4638-5p restoration.
  • Kidins220 activates the PI3K/AKT pathway, crucial for CRPC.
  • miR-4638-5p regulates angiogenesis via Kidins220, VEGF, and the PI3K/AKT pathway.

Conclusions:

  • Downregulation of miR-4638-5p contributes to CRPC development and progression.
  • The miR-4638-5p/Kidins220/PI3K/AKT axis is a key pathway in CRPC.
  • miR-4638-5p influences angiogenesis, impacting prostate cancer progression.
  • miR-4638-5p and its downstream effectors represent potential biomarkers and therapeutic targets for CRPC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K